Molecular Monitoring after Autologous Stem Cell Transplantation and Preemptive Rituximab Treatment of Molecular Relapse; Results from the Nordic Mantle Cell Lymphoma Studies (MCL2 and MCL3) with Median Follow-Up of 8.5 Years

Arne Kolstad; Lone Bredo Pedersen; Christian W. Eskelund; Simon Husby; Kirsten Gronbaek; Mats Jerkeman; Anna Laurell; Riikka Räty; Erkki Elonen; Niels Smedegaard Andersen; Peter deNully Brown; Eva Kimby; Hans Bentzen; Christer Sundstrom; Mats Ehinger; Marja-Liisa Karjalainen-Lindsberg; Jan Delabie; Elisabeth Ralfkiaer; Unn-Merete Fagerli; Herman Nilsson-Ehle; Grete Fossum Lauritzsen; Outi Kuittinen; Carsten Niemann; Christian Hartman Geisler; Nordic Lymphoma Grp

doi:10.1016/j.bbmt.2016.12.634

Molecular Monitoring after Autologous Stem Cell Transplantation and Preemptive Rituximab Treatment of Molecular Relapse; Results from the Nordic Mantle Cell Lymphoma Studies (MCL2 and MCL3) with Median Follow-Up of 8.5 Years

Arne Kolstad, Lone Bredo Pedersen, Christian W. Eskelund, Simon Husby, Kirsten Gronbaek, Mats Jerkeman, Anna Laurell, Riikka Räty, Erkki Elonen, Niels Smedegaard Andersen, Peter deNully Brown, Eva Kimby, Hans Bentzen, Christer Sundstrom, Mats Ehinger, Marja-Liisa Karjalainen-Lindsberg, Jan Delabie, Elisabeth Ralfkiaer, Unn-Merete Fagerli, Herman Nilsson-EhleGrete Fossum Lauritzsen, Outi Kuittinen, Carsten Niemann, Christian Hartman Geisler, Nordic Lymphoma Grp

Tutkimustuotos: Artikkelijulkaisu › Artikkeli › Tieteellinen › vertaisarvioitu

Alkuperäiskieli	englanti
Lehti	Biology of Blood and Marrow Transplantation
Vuosikerta	23
Numero	3
Sivut	428-435
Sivumäärä	8
ISSN	1083-8791
DOI - pysyväislinkit	https://doi.org/10.1016/j.bbmt.2016.12.634
Tila	Julkaistu - maalisk. 2017
OKM-julkaisutyyppi	A1 Alkuperäisartikkeli tieteellisessä aikakauslehdessä, vertaisarvioitu

Tieteenalat

3121 Yleislääketiede, sisätaudit ja muut kliiniset lääketieteet
3122 Syöpätaudit

Pääsy asiakirjaan

10.1016/j.bbmt.2016.12.634

MolecularLopullinen julkaistu versio, 1,89 MB

Siteeraa tätä

Kolstad, A., Pedersen, L. B., Eskelund, C. W., Husby, S., Gronbaek, K., Jerkeman, M., Laurell, A., Räty, R., Elonen, E., Andersen, N. S., Brown, P. D., Kimby, E., Bentzen, H., Sundstrom, C., Ehinger, M., Karjalainen-Lindsberg, M-L., Delabie, J., Ralfkiaer, E., Fagerli, U-M., ... Nordic Lymphoma Grp (2017). Molecular Monitoring after Autologous Stem Cell Transplantation and Preemptive Rituximab Treatment of Molecular Relapse; Results from the Nordic Mantle Cell Lymphoma Studies (MCL2 and MCL3) with Median Follow-Up of 8.5 Years. Biology of Blood and Marrow Transplantation, 23(3), 428-435. https://doi.org/10.1016/j.bbmt.2016.12.634

Kolstad, Arne ; Pedersen, Lone Bredo ; Eskelund, Christian W. et al. / Molecular Monitoring after Autologous Stem Cell Transplantation and Preemptive Rituximab Treatment of Molecular Relapse; Results from the Nordic Mantle Cell Lymphoma Studies (MCL2 and MCL3) with Median Follow-Up of 8.5 Years. Julkaisussa: Biology of Blood and Marrow Transplantation. 2017 ; Vuosikerta 23, Nro 3. Sivut 428-435.

@article{5fc860cf33ed40a592c43abe13f0dcb8,

title = "Molecular Monitoring after Autologous Stem Cell Transplantation and Preemptive Rituximab Treatment of Molecular Relapse; Results from the Nordic Mantle Cell Lymphoma Studies (MCL2 and MCL3) with Median Follow-Up of 8.5 Years",

keywords = "Mantle cell lymphoma, Autologous stem cell, transplantation, Minimal residual disease, Preemptive rituximab, MINIMAL RESIDUAL DISEASE, PROGRESSION-FREE SURVIVAL, TIME QUANTITATIVE PCR, RANDOMIZED-TRIALS, MULTIPLE-MYELOMA, PROGNOSTIC INDEX, IMMUNOCHEMOTHERAPY, REMISSION, NETWORK, PHASE-2, 3121 General medicine, internal medicine and other clinical medicine, 3122 Cancers",

author = "Arne Kolstad and Pedersen, {Lone Bredo} and Eskelund, {Christian W.} and Simon Husby and Kirsten Gronbaek and Mats Jerkeman and Anna Laurell and Riikka R{\"a}ty and Erkki Elonen and Andersen, {Niels Smedegaard} and Brown, {Peter deNully} and Eva Kimby and Hans Bentzen and Christer Sundstrom and Mats Ehinger and Marja-Liisa Karjalainen-Lindsberg and Jan Delabie and Elisabeth Ralfkiaer and Unn-Merete Fagerli and Herman Nilsson-Ehle and Lauritzsen, {Grete Fossum} and Outi Kuittinen and Carsten Niemann and Geisler, {Christian Hartman} and {Nordic Lymphoma Grp}",

year = "2017",

month = mar,

doi = "10.1016/j.bbmt.2016.12.634",

language = "English",

volume = "23",

pages = "428--435",

journal = "Biology of Blood and Marrow Transplantation",

issn = "1083-8791",

publisher = "EXCERPTA MEDICA INC-ELSEVIER SCIENCE INC",

number = "3",

}

Kolstad, A, Pedersen, LB, Eskelund, CW, Husby, S, Gronbaek, K, Jerkeman, M, Laurell, A, Räty, R , Elonen, E, Andersen, NS, Brown, PD, Kimby, E, Bentzen, H, Sundstrom, C, Ehinger, M, Karjalainen-Lindsberg, M-L, Delabie, J, Ralfkiaer, E, Fagerli, U-M, Nilsson-Ehle, H, Lauritzsen, GF, Kuittinen, O, Niemann, C, Geisler, CH & Nordic Lymphoma Grp 2017, 'Molecular Monitoring after Autologous Stem Cell Transplantation and Preemptive Rituximab Treatment of Molecular Relapse; Results from the Nordic Mantle Cell Lymphoma Studies (MCL2 and MCL3) with Median Follow-Up of 8.5 Years', Biology of Blood and Marrow Transplantation, Vuosikerta 23, Nro 3, Sivut 428-435. https://doi.org/10.1016/j.bbmt.2016.12.634

Molecular Monitoring after Autologous Stem Cell Transplantation and Preemptive Rituximab Treatment of Molecular Relapse; Results from the Nordic Mantle Cell Lymphoma Studies (MCL2 and MCL3) with Median Follow-Up of 8.5 Years. / Kolstad, Arne; Pedersen, Lone Bredo; Eskelund, Christian W. et al.

julkaisussa: Biology of Blood and Marrow Transplantation, Vuosikerta 23, Nro 3, 03.2017, s. 428-435.

Tutkimustuotos: Artikkelijulkaisu › Artikkeli › Tieteellinen › vertaisarvioitu

TY - JOUR

T1 - Molecular Monitoring after Autologous Stem Cell Transplantation and Preemptive Rituximab Treatment of Molecular Relapse; Results from the Nordic Mantle Cell Lymphoma Studies (MCL2 and MCL3) with Median Follow-Up of 8.5 Years

AU - Kolstad, Arne

AU - Pedersen, Lone Bredo

AU - Eskelund, Christian W.

AU - Husby, Simon

AU - Gronbaek, Kirsten

AU - Jerkeman, Mats

AU - Laurell, Anna

AU - Räty, Riikka

AU - Elonen, Erkki

AU - Andersen, Niels Smedegaard

AU - Brown, Peter deNully

AU - Kimby, Eva

AU - Bentzen, Hans

AU - Sundstrom, Christer

AU - Ehinger, Mats

AU - Karjalainen-Lindsberg, Marja-Liisa

AU - Delabie, Jan

AU - Ralfkiaer, Elisabeth

AU - Fagerli, Unn-Merete

AU - Nilsson-Ehle, Herman

AU - Lauritzsen, Grete Fossum

AU - Kuittinen, Outi

AU - Niemann, Carsten

AU - Geisler, Christian Hartman

AU - Nordic Lymphoma Grp

PY - 2017/3

Y1 - 2017/3

KW - Mantle cell lymphoma

KW - Autologous stem cell

KW - transplantation

KW - Minimal residual disease

KW - Preemptive rituximab

KW - MINIMAL RESIDUAL DISEASE

KW - PROGRESSION-FREE SURVIVAL

KW - TIME QUANTITATIVE PCR

KW - RANDOMIZED-TRIALS

KW - MULTIPLE-MYELOMA

KW - PROGNOSTIC INDEX

KW - IMMUNOCHEMOTHERAPY

KW - REMISSION

KW - NETWORK

KW - PHASE-2

KW - 3121 General medicine, internal medicine and other clinical medicine

KW - 3122 Cancers

U2 - 10.1016/j.bbmt.2016.12.634

DO - 10.1016/j.bbmt.2016.12.634

M3 - Article

VL - 23

SP - 428

EP - 435

JO - Biology of Blood and Marrow Transplantation

JF - Biology of Blood and Marrow Transplantation

SN - 1083-8791

IS - 3

ER -

Kolstad A, Pedersen LB, Eskelund CW, Husby S, Gronbaek K, Jerkeman M et al. Molecular Monitoring after Autologous Stem Cell Transplantation and Preemptive Rituximab Treatment of Molecular Relapse; Results from the Nordic Mantle Cell Lymphoma Studies (MCL2 and MCL3) with Median Follow-Up of 8.5 Years. Biology of Blood and Marrow Transplantation. 2017 maalis;23(3):428-435. doi: 10.1016/j.bbmt.2016.12.634